Faculty of 1000 evaluation for Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.

2013 ◽  
Author(s):  
Victoria Werth
Keyword(s):  
Hereditary Angioedema ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Repeat Treatment

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study

Allergy ◽  
2013 ◽  
Vol 68 (11) ◽  
pp. 1452-1459 ◽  
Author(s):  
M. Baş ◽  
J. Greve ◽  
T. K. Hoffmann ◽  
A. Reshef ◽  
W. Aberer ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Repeat Treatment

scholarly journals Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study

2020 ◽  
Vol 69 (2) ◽  
pp. 268-273 ◽  
Author(s):  
Michihiro Hide ◽  
Atsushi Fukunaga ◽  
Junichi Maehara ◽  
Kazunori Eto ◽  
James Hao ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Japanese Patients ◽  
Acute Attack ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Study ◽  
Label Study

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

2013 ◽  
Vol 110 (4) ◽  
pp. 295-299 ◽  
Author(s):  
Marc A. Riedl ◽  
Robyn J. Levy ◽  
Daniel Suez ◽  
Richard F. Lockey ◽  
James W. Baker ◽  
...  
Keyword(s):  
North American ◽  
Hereditary Angioedema ◽  
Efficacy And Safety ◽  
C1 Inhibitor ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Azathloprise in refractory sprue. Results from a prospective open-label study

2001 ◽  
Vol 120 (5) ◽  
pp. A392-A392 ◽  
Author(s):  
S NIVELONI ◽  
A CHERNAVSKY ◽  
S PEDREIRA ◽  
R MAZURE ◽  
H VAZQUEZ ◽  
...  
Keyword(s):  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Refractory Sprue
Sign in / Sign up

Export Citation Format

Share Document